VRNA: Verona Pharma plc Company Profile & Statistics

About

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

Info & Links

CEO

David Zaccardelli

Headquarters

3 MORE LONDON RIVERSIDE
LONDON, X0 SE1 2RE, UNITED KINGDOM

Auditor

Ernst & Young LLP

Share holders

Employees

209

Verona Pharma plc Statistics

Valuation Measures

Market Capitalization²

37.20B

Enterprise Value

36.93B

Enterprise Value/EBITDA(ttm)

-242.50

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

40.25

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

46.20%

Operating Margin(ttm)

Profit Margin(ttm)

-214.05%

Return on Equity(ttm)

-79.54%

Return on Invested Capital(ttm)

-61.32%

Return on Assets(ttm)

-43.49%

Income Statement

Revenue(ttm)

42.28M

Revenue Per Share(ttm)

0.50

Gross Profit(ttm)

39.70M

EBITDA(ttm)³

-152.26M

Net Income Available to Common(ttm)

-173.42M

Diluted EPS(ttm)

-1.92

Share Statistics

Beta (5Y Monthly)

0.41

52-Week Change

278.81%

S&P 500 52-Week Change

8.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

84.98M

Dividend Yield

0.00%

Float⁴

76.10M

% Held by Insiders

4.80%

% Held by Institutions

85.88%

Balance Sheet

Total Cash(mrq)

399.76M

Total Cash Per Share(mrq)

4.70

Total Debt(mrq)

120.34M

Total Debt/Equity(mrq)

58.83%

Current Ratio(mrq)

10.63%

Quick Ratio(mrq)

12.88%

Book Value Per Share(mrq)

2.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.50

Free Cash Flow(ytd)

-122.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VRNA

Verona Pharma plc

Verona Pharma plc Profile